Latest Breaking News On - Doubling tear production - Page 1 : comparemela.com

Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye disease (DED).

Managing dry eye diseaseTrial presentedOpen labelSingle arm studyIncomplete responseDry eye diseaseCorneal stainingSande scoreSymptom assessment questionnaire in dry eye corneal stainingCentral corneal stainingArtificial tearsFda trialsTotal corneal clearingDoubling tear productionIncomplete response dry eye disease